UMMC researcher’s pioneering work gives rise to new severe depression drug
Thirty years ago, Dr. Ian Paul and a group of fellow young researchers had a hypothesis: that major depression has a connection with the brain neurotransmitter glutamate, and that drugs that block glutamate receptors would have an anti-depressive effect. It proved true, making possible the highly acclaimed drug esketamine, the first truly new depression treatment in three decades.
Published on Thursday, March 21, 2019
Community, training centers add to Jackson Heart Study's mission
On Feb. 16, the Jackson Heart Study formally launched its Community Engagement Center, a new component that expands the study's ability to translate its findings into better cardiovascular health. The JHS’s new Graduate Training and Education Center at UMMC is also preparing for its first cohort of students.
Published on Thursday, February 21, 2019
More accessible research partnerships lead to greater medical progress
It's been proven that medicine can’t advance without clinical research, and clinical research can’t happen without human volunteers. Clinicians and administrators discuss the importance of communication between participants and study investigators and how UMMC is making research partnerships more accessible.
Published on Monday, February 18, 2019